| Cancer statistics, 2020 | Ca-A Cancer Journal for Clinicians | 2020 | 10.2K |
| Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China | Lancet Oncology, The | 2020 | 2.5K |
| Colorectal cancer statistics, 2020 | Ca-A Cancer Journal for Clinicians | 2020 | 1.5K |
| Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China | Cell Host and Microbe | 2020 | 1.3K |
| Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure | Cell Host and Microbe | 2020 | 1.2K |
| Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer | Journal of Thoracic Oncology | 2020 | 846 |
| Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China | Annals of Oncology | 2020 | 838 |
| Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak | Cancer Discovery | 2020 | 830 |
| A framework for advancing our understanding of cancer-associated fibroblasts | Nature Reviews Cancer | 2020 | 790 |
| Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study | Journal of Clinical Oncology | 2020 | 786 |
| Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey | Journal of Translational Medicine | 2020 | 720 |
| SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China | JAMA Oncology | 2020 | 656 |
| The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study | Lancet Oncology, The | 2020 | 634 |
| A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 | Cell Host and Microbe | 2020 | 615 |
| Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial | Journal of Clinical Oncology | 2020 | 600 |
| Infection and Rapid Transmission of SARS-CoV-2 in Ferrets | Cell Host and Microbe | 2020 | 577 |
| Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology | 2020 | 570 |
| Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant | Journal of Translational Medicine | 2020 | 558 |
| Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients | Cell Host and Microbe | 2020 | 528 |
| Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer | International Journal of Clinical Oncology | 2020 | 517 |
| Ferroptosis: past, present and future | Cell Death and Disease | 2020 | 508 |
| Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study | Lancet Oncology, The | 2020 | 500 |
| Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update | Journal of Clinical Oncology | 2020 | 479 |
| Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials | Lancet Oncology, The | 2020 | 454 |
| Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System | Cancer Discovery | 2020 | 448 |
